SCHEMBL17325883

SCHEMBL17325883

CCCCN(CCCC)CCOC(=O)C(C)(CC(C)C)C(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 5/20 0.36
CHRM1 P11229 3/20 0.36
CHRM3 P20309 3/20 0.36
CHRM4 P08173 2/20 0.36
CHRM5 P08912 1/20 0.36
LMNA P02545 4/20 0.35
CYP1A2 P05177 4/20 0.35
CYP2D6 P10635 4/20 0.35
CYP3A4 P08684 4/20 0.35
SCN1A P35498 2/20 0.35
SCN2A Q99250 2/20 0.35
SCN3A Q9NY46 2/20 0.35
GAA P10253 2/20 0.35
HTR1A P08908 1/20 0.35
DRD3 P35462 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KCNH2 Q12809 1/20 0.35
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
MMP8 P22894 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17325885 0.96 CHRM2 (0.35) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL17325884 0.91 CHRM2 (0.38) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL23395168 0.87 LMNA (0.40) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL17325882 0.87 CHRM2 (0.48) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL17325886 0.86 MMP8 (0.33) CHRM2CHRM1CHRM3MMP8DNM1
SCHEMBL17325879 0.86 CHRM2 (0.42) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL25007448 0.85 ALDH1A1 (0.42) LMNACYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL5511415 0.82 CHRM2 (0.39) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL807035 0.81 MMP8 (0.41) CHRM1LMNAMMP8TSHRALDH1A1
SCHEMBL10124341 0.80 CHRM1 (0.43) CHRM2CHRM1CHRM3CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723990-B2 Library of pH responsive polymers and nanoprobes thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-08-15 US disclosed
US-11723990-B2 Library of pH responsive polymers and nanoprobes thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-08-15 US disclosed
US-20210338840-A1 LIBRARY OF PH RESPONSIVE POLYMERS AND NANOPROBES THEREOF THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-11-04 US disclosed
US-20200333357-A1 NOVEL TFEB PATHWAY AGONISTS FOR METABOLIC DISEASES AND AGEING THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2020-10-22 US disclosed
US-20170143852-A1 LIBRARY OF PH RESPONSIVE POLYMERS AND NANOPROBES THEREOF THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2017-05-25 US disclosed
WO-2015188157-A1 LIBRARY OF PH RESPONSIVE POLYMERS AND NANOPROBES THEREOF THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2015-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200333357-A1 NOVEL TFEB PATHWAY AGONISTS FOR METABOLIC DISEASES AND AGEING TFEB, GPR119, SQSTM1 CHRM2 3948/4885CHRM1 4146/4885CHRM3 4235/4885
US-20210338840-A1 LIBRARY OF PH RESPONSIVE POLYMERS AND NANOPROBES THEREOF MSN, CD44, CD47 CHRM2 4022/4885CHRM1 4328/4885CHRM3 3699/4885
US-20170143852-A1 LIBRARY OF PH RESPONSIVE POLYMERS AND NANOPROBES THEREOF MSN, CD44, CD47 CHRM2 4022/4885CHRM1 4328/4885CHRM3 3699/4885
US-11723990-B2 Library of pH responsive polymers and nanoprobes thereof MSN, CD44, CD47 CHRM2 4022/4885CHRM1 4328/4885CHRM3 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.